Mandate

Vinge advises Precio Fishbone in connection with the sale of shares in a subsidiary company

Vinge advises Precio Fishbone AB (publ) (”Precio Fishbone”) in connection with the sale of approximately 80.1 per cent of the shares in the subsidiary Precio Fishbone Systems AB ("Omnia"), including the product Omnia Digital Workplace, to Monterro.

Omnia Digital Workplace has been awarded in several different international contexts and has for six consecutive years been ranked as the market's best SaaS product for creating a modern digital workplace.

Monterro acquires a majority stake of approximately 80.1 per cent in Omnia from Precio Fishbone while Precio Fishbone retains a minority stake of approximately 19.9 per cent. Omnia has been created through a restructuring whereby all operations and employees related to the product Omnia Digital Workplace have been transferred from Precio Fishbone to the previously wholly owned subsidiary Omnia. All shares in Omnia are transferred to a company that will be indirectly owned by Monterro and Precio Fishbone. The purchase price for the approximately 80.1 per cent of the shares in Omnia indirectly transferred to Monterro amounts to SEK 168 million. Omnia also owns Omnia Systems Ltd (Vietnam), Precio Fishbone Canada Inc, Precio Fishbone Danmark ApS and has a branch in Germany.

Vinge’s team consisted of Matthias Pannier, Gustav Persson, Maximilian Bengtsson (M&A), Dain Hård Nevonen, William Kåge (Capital Markets), Mathilda Persson (Corporate Commercial), Rebecka Målquist (Intellectual Property) and Fanny Askelöf (Transaction Support Specialist).

Related

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026

Vinge advises KEYTO Group in connection with the acquisition of Smartify

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Smartify Sverige AB joins KEYTO Group.
January 19, 2026

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026